What We Know So Far About ECG for Pancreatic Pseudocysts

被引:0
|
作者
Kluszczyk, Paulina [1 ]
Jablonska, Beata [2 ]
Serafin, Michal [1 ]
Tobiasz, Aleksandra [1 ]
Kowalczyk, Tomasz [1 ]
Maslanka, Sebastian [1 ]
Chapula, Mateusz [3 ]
Wosiewicz, Piotr [3 ]
Mrowiec, Slawomir [2 ]
机构
[1] Med Univ Silesia, Fac Med Sci Katowice, Dept Digest Tract Surg, Student Sci Soc, Medykow 14 St, PL-40752 Katowice, Poland
[2] Med Univ Silesia, Fac Med Sci Katowice, Dept Digest Tract Surg, Medykow 14 St, PL-40752 Katowice, Poland
[3] Med Univ Silesia, Fac Med Sci Katowice, Dept Gastroenterol & Hepatol, Medykow 14 St, PL-40752 Katowice, Poland
来源
LIFE-BASEL | 2024年 / 14卷 / 11期
关键词
post-inflammatory pancreatic cysts; endoscopic internal drainage; endoscopic cystogastrostomy; GUIDED TRANSMURAL DRAINAGE; EXPANDING METAL STENTS; WALLED-OFF NECROSIS; SURGICAL-TREATMENT; ENDOSCOPIC TREATMENT; FLUID COLLECTIONS; CLINICAL-OUTCOMES; PLASTIC STENTS; MANAGEMENT; EFFICACY;
D O I
10.3390/life14111419
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Endoscopic cysto-gastrostomy (ECG) has become the treatment of choice for pancreatic pseudocysts (PPCs). Endoscopic drainage of PPCs requires the creation of an anastomosis between the lumen of the PPCs and the lumen of the gastrointestinal tract. Various types of stents are used for this purpose. The aim of the study is to compare the indications, quantity, and results of using double pigtail plastic stents (DPPSs) and lumen-apposing fully covered metal stents (LAMSs) in ECG. Methods: A retrospective analysis was conducted of 39 patients (24 men, 15 women) treated for PPCs in the Department of Digestive Tract Surgery and the Department of Gastroenterology and Hepatology between October 2018 and February 2023. The mean age of patients was 51.13 (28-77). Data about etiology, cyst diameter, type, and complications of the stents were collected. Results: DPPSs were placed in smaller cysts (108 vs. 140 millimeters, p = 0.04) and were maintained for a longer duration compared to LAMSs (106 vs. 34 days, p = 0.001). Cyst recurrence was reported less frequently in patients with a LAMS (0 (0%) vs. 4 (19.05%), p = 0.05) and the therapeutic success was non-significantly higher in the LAMS group compared to the DPPS group (100% vs. 85.71%), p = 0.095. Conclusions: Both DPPSs and LAMSs are characterized by high therapeutic success and low complication rates in patients undergoing ECG for PPCs.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Ketogenic Diet and Epilepsy: What We Know So Far
    Meira, Isabella D'Andrea
    Romao, Tayla Taynan
    Pires do Prado, Henrique Jannuzzelli
    Kruger, Lia Theophilo
    Paiva Pires, Maria Elisa
    da Conceicao, Priscila Oliveira
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [2] Incremental Hemodialysis: What We Know so Far
    Soi, Vivek
    Faber, Mark D.
    Paul, Ritika
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2022, 15 : 161 - 172
  • [3] Fire effects on anurans: What we know so far?
    dos Anjos, Amanda Gomes
    Sole, Mirco
    Benchimol, Maira
    FOREST ECOLOGY AND MANAGEMENT, 2021, 495
  • [4] Pirfenidone use in fibrotic diseases: What do we know so far?
    Torre, Aldo
    David Martinez-Sanchez, Froylan
    Mercedes Narvaez-Chavez, Sofia
    Ariel Herrera-Islas, Mariana
    Alberto Aguilar-Salinas, Carlos
    Cordova-Gallardo, Jacqueline
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (07)
  • [5] Scalp Seborrheic Dermatitis: What We Know So Far
    Leroy, Anne Kelly
    de Almeida, Rita Fernanda Cortez
    Obadia, Daniel Lago
    Frattini, Sidney
    Melo, Daniel Fernandes
    SKIN APPENDAGE DISORDERS, 2023, 9 (03) : 160 - 164
  • [6] Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review
    Tilak, Mandar
    Tewari, Mallika
    Shukla, H. S.
    INDIAN JOURNAL OF CANCER, 2023, 60 (02) : 152 - 159
  • [7] Lisfranc Sports Injuries: What Do We Know So Far?
    Maduka, Godsfavour C.
    Maduka, Divinegrace C.
    Yusuf, Naeem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [8] Eosinophilic Esophagitis-What Do We Know So Far?
    Wasik, Jakub
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [9] Relationships and networks in context: what do we know so far?
    ALHussan, Fawaz Baddar
    Batt, Peter J.
    Al-Husan, Faten Baddar
    JOURNAL OF BUSINESS & INDUSTRIAL MARKETING, 2021, 36 (11) : 1957 - 1961
  • [10] Omalizumab for successful chemotherapy desensitisation: What we know so far
    Bumbacea, Roxana Silvia
    Ali, Selda
    Corcea, Sabina Loredana
    Spiru, Luiza
    Nitipir, Cornelia
    Strambu, Victor
    Bumbacea, Dragos
    CLINICAL AND TRANSLATIONAL ALLERGY, 2021, 11 (10)